Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Avantor, Inc. (AVTR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Gourdier Benoit (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 16,786 shares
@ $0
Granted 39,281 options to buy
@ $20.85, valued at
$819k
|
|
| 08/09/2023 |
4
| Jones R. Brent (EVP, CFO) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 295,559 options to buy
@ $20.76, valued at
$6.1M
|
|
| 08/02/2023 |
4
| Eck Steven W (SVP & Chief Accounting Officer) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 14,584 shares
@ $0 |
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2023 |
4
| Stubblefield Michael (President & CEO) has filed a Form 4 on Avantor, Inc.|
Txns:
| Gifted 40,000 shares
@ $0
Gifted 40,000 shares
@ $0 |
|
| 05/19/2023 |
4
| Couturier Christophe (EVP, AMEA) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 15,706 shares
@ $20.28, valued at
$318.5k
|
|
| 05/19/2023 |
4
| Miller Justin (EVP & General Counsel) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 12,449 shares
@ $20.28, valued at
$252.5k
|
|
| 05/19/2023 |
4
| Stubblefield Michael (President & CEO) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 106,200 shares
@ $20.28, valued at
$2.2M
|
|
| 05/19/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 19,683 shares
@ $20.28, valued at
$399.2k
|
|
| 05/19/2023 |
4
| Eck Steven W (SVP & Chief Accounting Officer) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 553 shares
@ $20.28, valued at
$11.2k
|
|
| 05/19/2023 |
4
| Vanderhaegen Frederic (EVP, Americas and Europe) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 2,210 shares
@ $20.28, valued at
$44.8k
|
|
| 05/19/2023 |
4
| Szlosek Thomas A (EVP & CFO) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 23,261 shares
@ $20.28, valued at
$471.7k
|
|
| 05/19/2023 |
4
| Bramwell James (EVP, Strategic Partners) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 18,917 shares
@ $20.28, valued at
$383.6k
|
|
| 05/15/2023 |
4
| SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| SUMME GREGORY L (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| Murthy Mala (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| Carethers John (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| Kang Lan (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| Massaro Joseph R (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| Andres Juan (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/15/2023 |
4
| Shaw Christi (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2023 |
4
| Couturier Christophe (EVP, AMEA) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 569 shares
@ $20.82, valued at
$11.8k
|
|
| 03/06/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 3,914 shares
@ $25, valued at
$97.9k
|
|
| 03/01/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 3,059 shares
@ $25, valued at
$76.5k
|
|
| 03/01/2023 |
4
| Couturier Christophe (EVP, AMEA) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 2,324 shares
@ $24.32, valued at
$56.5k
|
|
| 02/27/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 1,893 shares
@ $24.59, valued at
$46.5k
Granted 20,308 shares
@ $0
Paid exercise price by delivering 2,040 shares
@ $24.62, valued at
$50.2k
Granted 49,215 options to buy
@ $24.62, valued at
$1.2M
|
|
| 02/27/2023 |
4
| Eck Steven W (SVP & Chief Accounting Officer) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 421 shares
@ $24.59, valued at
$10.4k
Granted 5,347 shares
@ $0
Paid exercise price by delivering 505 shares
@ $24.62, valued at
$12.4k
Granted 12,963 options to buy
@ $24.62, valued at
$319.1k
|
|
| 02/27/2023 |
4
| Szlosek Thomas A (EVP & CFO) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 2,082 shares
@ $24.59, valued at
$51.2k
Granted 22,339 shares
@ $0
Paid exercise price by delivering 2,040 shares
@ $24.62, valued at
$50.2k
Granted 54,135 options to buy
@ $24.62, valued at
$1.3M
|
|
| 02/27/2023 |
4
| Vanderhaegen Frederic (EVP, Americas and Europe) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 213 shares
@ $24.59, valued at
$5.2k
Granted 20,308 shares
@ $0
Paid exercise price by delivering 299 shares
@ $24.62, valued at
$7.4k
Granted 49,215 options to buy
@ $24.62, valued at
$1.2M
|
|
| 02/27/2023 |
4
| Couturier Christophe (EVP, AMEA) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 416 shares
@ $24.59, valued at
$10.2k
Sold 3,078 shares
@ $24.24, valued at
$74.6k
Granted 9,138 shares
@ $0
Paid exercise price by delivering 467 shares
@ $24.62, valued at
$11.5k
Granted 22,149 options to buy
@ $24.62, valued at
$545.3k
|
|
| 02/27/2023 |
4
| Henson Meghan (EVP, Chief HR Officer) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 816 shares
@ $24.59, valued at
$20.1k
Granted 12,185 shares
@ $0
Paid exercise price by delivering 800 shares
@ $24.62, valued at
$19.7k
Granted 29,529 options to buy
@ $24.62, valued at
$727k
|
|
|
|
|